No Detail Found!

Guiding methimazole therapy of autoimmune thyroid disease with thyroid antibody profiles: A predictive and causal inference study

Author(s)
Tao Yong Department, Huainan Sunshine Xinkang Hospital,,China
Liu Qiong Department, Huainan Sunshine Xinkang Hospital,,China
Abstract
The predictiveness and diagnostic utility of thyroid antibodies-thyroid-stimulating hormone receptor antibody, anti-thyroglobulin antibody and anti-thyroid peroxidase antibody-were investigated in autoimmune thyroid disease. The charts of 85 patients with Hashimoto's thyroiditis or Graves' disease were retrospectively analyzed with causal inference techniques and machine learning algorithms to estimate adjusted associations and interactions among antibodies. The most robust estimated disease diagnosis association was with anti-thyroid peroxidase antibody (mean treatment effect = 0.731) which also gave the best predictive accuracy (area under the receiver operating characteristic curve = 0.875) especially in the middle-aged and older population. Predictive accuracy was enhanced by using several antibodies (area under the curve = 0.913) whereas, interaction effects were trivial. Thyroid-stimulating hormone receptor antibody positivity was highly predictive of the clinical decision to start Methimazole treatment in Graves' disease. The findings suggest that anti-thyroid peroxidase antibody preference for screening and thyroid antibody profile use in treatment planning can guide clinical decision-making, within the constraints of causal inference assumption employed.
Publication Details
Page(s) 2379-2391
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 6, Year: 2025

Request the full text from PASTIC

Keywords
Hashimoto's thyroiditis, methimazole, Autoimmune thyroid disease, Graves' disease, Thyroid antibodies, TPOAb, TRAb, Precision diagnostics, Personalized therapy
References
Ajayi AF,Adebayo ET,Adebayo IO,Oyekunle OS,Amos VO,Bamidele SE,Olatinwo GO .2022 .Application of data science approaches to investigate autoimmune thyroid disease. Hypothyroidism: New Aspects of an Old Disease, : 23.
Alsahabi SA,Daghriri HH,Almutairi RA,Alrbaee AM,Khamees AF,Hubaysh LA,Alghamdi KA,Zughibi HM,Alssaygh AA,Makrami HA,Alshahrani MS .1947 .A review of laboratory advancements in thyroid stimulating receptor autoantibodies assays: Diagnostic and clinical applications. J. Int. Crisis Risk Commun. Res., 7(S9) : .
AL Majali S,Ebadi M,Ebadi Z,AG Z .2025 .Integrating nutrition and mental health: Mechanistic pathways, clinical evidence and public health policy implications. Wah Acad. J. Health Nutr, 1(2) : 33-40.
Azizi F,Amouzegar A,Khalili D,Abdi H,Tohidi M,Hedayati M,Cheraghi L,Mehrabi Y,Takyar M Y .2024 .Risk of recurrence at the time of withdrawal of short- or long-term methimazole therapy in patients with Graves' hyperthyroidism: a randomized trial and a riskscoring model. Endocrine, 84(2) : 577-88.
Bolakale-Rufai IK,Abioro I,Ngene SO,Woldeamanuel Y .2023 .Efficacy of methimazole before the administration of radioactive iodine in the management of Graves' disease: A systematic review and meta-analysis. Sao Paulo Med. , 141(5) : e2022225.
Chan FY,Ku YE,Lie WN,Chen HY .2025 .Webbased explainable machine learning-based drug surveillance for predicting sunitinib-and sorafenibassociated thyroid dysfunction: Model development and validation study. JMIR Form. Res., 9 : e67767.
Czarnywojtek A,Florek E,Pietronczyk K,Sawicka-Gutaj N,Ruchała M,Ronen O,Nixon IJ,Shaha AR,Rodrigo JP,Tufano RP,Zafereo M .2023 .The role of vitamin D in autoimmune thyroid diseases: a narrative review. J. Clin. Med, 12(4) : 1452.
Dwivedi SN,Kalaria T,Buch H T .2023 .Thyroid autoantibodies. J. Clin. Pathol, 76(1) : 19-28.
Ebadi AG .2025 .Synergistic approaches in diabetes management: The role of anti-diabetic drugs and herbal medicine in therapeutic strategies. Nepal J. Med. Sci., 10(2) : 68-81.
Ebadi AG,Selamoglu Z AG .2025 .Exploring the role of herbal medicines in modern pharmacology and drug development. Lat. Am. J. Pharm., 44(4) : 401-406.
Gallo D,Bruno A,Gallazzi M,Cattaneo SA,Veronesi G,Genoni A,Tanda ML,Bartalena L,Passi A,Piantanida E,Mortara L E .2023 .Immunomodulatory role of vitamin D and selenium supplementation in newly diagnosed Graves' disease patients during methimazole treatment. Front. Endocrinol., 14 : 1145811.
Gu P,Pu B,Ma Y,Yue D,Xin Q,Li H,Liu T,Zheng X,Ouyang C .2023 .Appraising the causal relationship between thyroid function and rheumatoid arthritis: A two-sample bidirectional Mendelian randomization study. Front. Immunol., 14 : 1238757.
Han Z,Cen C,Ou Q,Pan Y,Zhang J,Huo D,Chen K D .2022 .The potential prebiotic berberine combined with methimazole improved the therapeutic effect of Graves' disease patients through regulating the intestinal microbiome. Front. Immunol., 12 : 826067.
Jiang Z,Li S,Yang L,Song X,Zhang X,Guo L,Guo J,Zhang H,Chen D H .2025 .Diagnostic value of serum TSI levels in Graves' disease and direct comparison of diagnostic performance with TRAb: A systematic review and meta-analysis. Clin. Biochem, 110989 : .
Kalra S,Selim S,Shrestha D,Somasundaram N,Raza SA,Baruah MP,Bhattacharya S,Gadve S,Bantwal G,Sahay R G .2024 .Best practices in the laboratory diagnosis, prognostication, prediction and monitoring of Graves' disease: role of TRAbs. , 24(1) : 274.
Bulow-Pedersen Karmisholt J andersen SL,Krejbjerg I,Nygaard A,Carle B,A B .2022 .Long-term methimazole therapy in Graves' hyperthyroidism and adverse reactions: A Danish multicenter study. Eur. Thyroid J., 11(3) : .
Ke C,Yu Y,Li J,Yu Y,Sun Y,Wang Y,Wang B,Lu Y,Tang M,Wang N,Chen Y .2025 .Genetic and plasma proteomic approaches to identify therapeutic targets for Graves' disease and Graves' ophthalmopathy. , : 87-98.
Khafaei M,Sadeghi Hajiabadi M and Abdolmaleki A .2021 .Role of 1,25-dihydroxycholecalciferol in immunological and molecular pathways involved in Multiple Sclerosis. Cent. Asian J. Med. Pharm. Sci. Innov, 1(2) : 55-66.
Kobayashi G,Okamura T,Hashimoto Y,Sakai K,Sumi M,Imai D,Kitagawa N,Hamaguchi M,Fukui M M .2025 .Pathogenesis of Graves' disease determined using single-cell sequencing with thyroid autoantigen peptide stimulation in B cells. Cells, 14(14) : 1102.
Kravchenko V,Zakharchenko T .2023 .Thyroid hormones and minerals in immunocorrection of disorders in autoimmune thyroid diseases. Front. Endocrinol., 14 : 1225494.
Lanzolla G,Marino M,Menconi F M .2024 .Graves' disease: Latest understanding of pathogenesis and treatment options. Nat. Rev. Endocrinol., 20(11) : 647-60.
Liu Q,Yang H,Chen Y,He X,Dong L,Zhang X,Yang Y,Tian M,Cheng W,Liu D,Yang G .2024 .Effect of thyroid peroxidase antibody titers trajectories during pregnancy and postpartum on postpartum thyroid dysfunction. Arch, 310(6) : 3229-38.
Ludgate ME,Masetti G,Soares P .2024 .The relationship between the gut microbiota and thyroid disorders. Nat. Rev. Endocrinol., 20(9) : 511-25.
Morshed S,Latif R,Davies TF .2023 .Signal responses to neutral TSH receptor antibody - A cycle of damage in the pathophysiology of Graves' disease. J. Autoimmun., 136 : 103012.
Ngan TT,Tra DH,Mai NT,Dung HV,Khai NV,Linh PV,Phuong NT .2025 .Developing a machine learningbased predictive model for levothyroxine dosage estimation in hypothyroid patients: A retrospective study. Front. Endocrinol., 16 : 1415206.
Othman RA .2023 .The frequency of thyroid stimulating blocking antibodies (TSBAbs) in individuals with newly diagnosed AITD. Cent. Asian J. Med. Nat. Sci., 4(5) : 38-44.
Ozdemir B,Khan A,Farooq Rashid R .2022 .The physiology of vitamin D and its involvement in cardiovascular diseases. Cent. Asian J. Med. Pharm. Sci. Innov, 2(4) : 128-140.
Pourzardosht N,Hashemi ZS,Mard-Soltani M,Jahangiri A,Rahbar MR,Zakeri A,Mirzajani E,Khalili S .2022 .Liothyronine could block the programmed death-ligand 1 (PDL1) activity: An e-pharmacophore modeling and virtual screening study. J. Recept. Signal Transduct, 42(1) : 34-42.
Rufino-Moya PJ,Zafra Leva R,Martinez-Moreno A,Buffoni L,Valderas Garcia E,Perez Arevalo J,MolinaHernandez V,Ruiz-Campillo MT,Herrera-Torres G,Martínez-Moreno FJ .2024 .Advancement in diagnosis, treatment and vaccines against Fasciola hepatica: A comprehensive review. Pathogens, 13(8) : 669.
Shang S,Xia J,He G,Zheng Y,Zhang J,Lu H,Wang H,Li W,Li Q,Chen X .2025 .Advances in precision medicine for lupus nephritis: Biomarker- and AI-driven diagnosis and treatment response prediction and targeted therapies. EBioMedicine, 117 : .
Sharma SD,Bluett J .2024 .Towards personalized medicine in rheumatoid arthritis. Open Access Rheumatol. Res. Rev., 89 : 114.
Silva AC,Damas II,Moma CA,Barreto IS,ZantutWittmann DE IS .2024 .Lower proportion of intrathyroidal B lymphocytes CD20+ associated to methimazole and lack of influence of iodide on lymphocyte subpopulations in Graves' disease. Mol. Cell, 592 : 112331.
Starosz A,Stożek K,Opęchowska A,Bossowski F,Moniuszko M,Grubczak K,Bossowski A .2024 .Effect of methimazole treatment on Th1, Th17 and Th22 lymphocytes in pediatric Graves' disease patients. Front. Immunol., 15 : 1431686.
Stasiak M,Stasiak B,Zawadzka-Starczewska K,Lewiński A .2023 .Significance of HLA in Graves' disease and Graves' orbitopathy in Asian and Caucasian populations - A systematic review. Front. Immunol., 14 : 1256922.
Takizawa H,Uchida T,Suzuki N,Onose H,Yamada E,Hashimoto K,Watanabe N,Nishida Y,Watada H Y .2025 .Influence of therapeutic inorganic iodine on long-term prognosis of Graves' disease: A multicenter prospective observational study. Endocr. J., 72(6) : 663-70.
Theiler-Schwetz V,Benninger T,Trummer C,Pilz S C .2022 .Mathematical modeling of free thyroxine concentrations during methimazole treatment for Graves' disease: Development and validation of a computer-aided thyroid treatment method. Front. Endocrinol., 13 : 841888.
Trzos S,Link-Lenczowski P,Sokołowski G,Pocheć E .2022 .Changes of IgG N-glycosylation in thyroid autoimmunity: the modulatory effect of methimazole in Graves' disease and the association with the severity of inflammation in Hashimoto's thyroiditis. Front. Immunol., 13 : 841710.
Vargas-Uricoechea H .2023 .Molecular mechanisms in autoimmune thyroid disease. Cells, 12(6) : 918.
Vargas-Uricoechea H,Nogueira JP,Pinzón-Fernández MV,Schwarzstein D MV .2023 .The usefulness of thyroid antibodies in the diagnostic approach to autoimmune thyroid disease. Antibodies, 12(3) : 48.
Wang Z,Bai J,Zou J,Yuan Y,Li S,Wang M .2024 .Association between thyroid autoimmunity and bone mineral density in patients with type 2 diabetes mellitus: a cross-sectional study. Endocrine, 85(2) : 604-14.
Wei M,Chu CQ M .2022 .Prediction of treatment response: Personalized medicine in the management of rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol, 36(1) : 101741.
Wu S,Yi J,Wu B .2024 .Casual associations of thyroid function with inflammatory bowel disease and the mediating role of cytokines. Front. Endocrinol., 15 : 1376139.
Xie P,Shen L,Peng R,Wang Y,Yin Q,Chen X,Jin Z,Ning G,Wang W,Wang S,Zhou Y .2025 .Effects of low-dose methotrexate with methimazole in patients with Graves' disease: Results of a randomized clinical trial. J. Clin. Endocrinol. Metab., 110(2) : 489-97.
Yang R,Li W,Niu Q,Yang W,Gu W,Wang X .2025 .Machine learning in lymphocyte and immune biomarker analysis for childhood thyroid diseases in China. , 25(1) : 249.
Yang Y,Chen H Y .2025 .Clinical application of thyrotropin receptor antibodies. Horm. Metab. Res., 57(2) : 79-87.
Yao P,Xie Y,Wang Y,Liang C,Huang B C .2024 .Comparison between thyroid stimulating immunoglobulin and TSH-receptor antibodies in the diagnosis and management of Graves' disease. Front. Endocrinol., 15 : 1487490.
Yao Z,Guo F,Tan Y,Zhang Y,Geng Y,Yang G,Wang S G .2024 .Causal relationship between inflammatory cytokines and autoimmune thyroid disease: A bidirectional two-sample Mendelian randomization analysis. Front. Immunol., 15 : 1334772.
Yu Y,Tong K,Deng J,Wu J,Yu R,Xiang Q .2025 .Unveiling the connection between micronutrients and autoimmune thyroiditis: Are they true friends? Biol. Trace Elem. , : 1-2.
Zhang C,Teng W,Wang C .2024 .The gut microbiota and its metabolites and their association with the risk of autoimmune thyroid disease: A Mendelian randomization study. Nutrients, 16(22) : 3898.
Zhang X,Zhao Q,Li B .2023 .Current and promising therapies based on the pathogenesis of Graves' ophthalmopathy. , 14 : 1217253.
Zheng H,Xu J,Chu Y,Jiang W,Yao W,Mo S,Song X,Zhou J .2022 .A global regulatory network for dysregulated gene expression and abnormal metabolic signaling in immune cells in the microenvironment of Graves' disease and Hashimoto's thyroiditis. Front. Immunol., 13 : 879824.
Zhuang DR,Hu X,Huang HB .2025 .Hub genes and key pathways of Graves' disease: Bioinformatics analysis and validation. Hormones, 24(3) : 605-619.
0

Citations

0

Downloads

85

Views